3-10289773-G-C

Variant summary

Our verdict is Uncertain significance.
+1 Uncertain · Cold
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 1 classification points (ACGS-UK Somatic Oncogenicity v2025). O3_ModerateB3_Supporting

The NM_016362.5(GHRL):c.214C>G (p.Leu72Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.000000689 (AC=1) in the gnomAD database across 1,451,160 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000000907. In-silico predictor (REVEL) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.L72M: Conflicting_classifications_of_pathogenicity (ClinVar VariationId 5062)

Frequency

Genomes: not found (cov: 31)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

GHRL
NM_016362.5 missense

Scores

3
16

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.30

Publications

104 publications found
Variant links:
Genes affected
GHRL (HGNC:18129): (ghrelin and obestatin prepropeptide) This gene encodes the ghrelin-obestatin preproprotein that is cleaved to yield two peptides, ghrelin and obestatin. Ghrelin is a powerful appetite stimulant and plays an important role in energy homeostasis. Its secretion is initiated when the stomach is empty, whereupon it binds to the growth hormone secretagogue receptor in the hypothalamus which results in the secretion of growth hormone (somatotropin). Ghrelin is thought to regulate multiple activities, including hunger, reward perception via the mesolimbic pathway, gastric acid secretion, gastrointestinal motility, and pancreatic glucose-stimulated insulin secretion. It was initially proposed that obestatin plays an opposing role to ghrelin by promoting satiety and thus decreasing food intake, but this action is still debated. Recent reports suggest multiple metabolic roles for obestatin, including regulating adipocyte function and glucose metabolism. Alternative splicing results in multiple transcript variants. In addition, antisense transcripts for this gene have been identified and may potentially regulate ghrelin-obestatin preproprotein expression. [provided by RefSeq, Nov 2014]
GHRLOS (HGNC:33885): (ghrelin opposite strand/antisense RNA) This gene is an antisense gene of the ghrelin/obestatin prepropeptide gene. Alternatively spliced transcript variants have been identified and they may function as non-coding regulatory RNAs. [provided by RefSeq, Jan 2013]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_016362.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Uncertain_significance. The variant received 1 points.

O3Absent or very rare in population
Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = 0.000001, AC = 1 — absent/extremely rare (O3 moderate [+2])
B3Computational evidence does not support deleterious effect
Computational evidence does not support a deleterious effect; Missense variant — primary computational scorer does not support an oncogenic/deleterious effect; supports B3

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_016362.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

GHRL NM_016362.5
MANE Select
HGVSc / HGVSpc.214C>Gp.Leu72Val
Exon rankExon 4 of 6
missense
Prot: NP_057446.1UniProt: Q9UBU3-1
GHRL NM_001302821.2
HGVSc / HGVSpc.214C>Gp.Leu72Val
Exon rankExon 5 of 7
missense
Prot: NP_001289750.1UniProt: Q9UBU3-1
GHRL NM_001302822.2
HGVSc / HGVSpc.214C>Gp.Leu72Val
Exon rankExon 4 of 6
missense
Prot: NP_001289751.1UniProt: Q9UBU3-1

Ensembl Transcripts

GHRL ENST00000335542.13
TSL:1MANE Select
HGVSc / HGVSpc.214C>Gp.Leu72Val
Exon rankExon 4 of 6
missense
Prot: ENSP00000335074.8UniProt: Q9UBU3-1
GHRL ENST00000429122.1
TSL:1
HGVSc / HGVSpc.214C>Gp.Leu72Val
Exon rankExon 4 of 6
missense
Prot: ENSP00000414819.1UniProt: Q9UBU3-1
GHRL ENST00000457360.5
TSL:1
HGVSc / HGVSpc.214C>Gp.Leu72Val
Exon rankExon 4 of 6
missense
Prot: ENSP00000391406.1UniProt: Q9UBU3-1

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:31
GnomAD4 exome
AF: 6.89e-7
AC:1
Hom:0
AN:1451160
Cov:30
GnomAD4 genome
Cov:31
Local & regional cohorts 1 source
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.000112
AC:1
Hom:0
AN:8960
Showing 4 sources

ClinVar

Not reported in ClinVar

Computational Scores

AlphaGenome AVI
Pathogenic21
AlphaMissense
Benign0.12
BayesDel_addAF
Benign-0.067T
BayesDel_noAF
Benign-0.33
CADD
Benign22
DANN
Uncertain0.99
DEOGEN2
Benign0.11T
Eigen
Uncertain0.30
Eigen_PC
Benign0.20
FATHMM_MKL
Uncertain0.79D
FuncVEP CTI
Benign0.20
GPN-Star LLR
N/A-3.4
GPN-Star score
N/A3.4
LIST_S2
Benign0.80T
M_CAP
Benign0.016T
MetaRNN
Benign0.27T
MetaSVM
Benign-0.82T
Mutation Taster
N/A92/8polymorphism
MutationAssessor
Benign1.8L
PhyloP100
Benign2.3
popEVE
Benign-3.0
PrimateAI
Benign0.43T
PromoterAI
N/A-0.010Neutral
PROVEAN
Benign-0.77N
REVEL
Benign0.061
Sift
Benign0.16T
Sift4G
Benign0.36T
Varity_R
N/A0.095
VESM-3B
Benign-5.2
Showing 29 of 29 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.010
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.